Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Nami Hayama"'
Autor:
Hajime Kasai, Go Saito, Kenichiro Takeda, Hiroshi Tajima, Chiaki Kawame, Nami Hayama, Kiyoshi Shikino, Ikuo Shimizu, Kazuyo Yamauchi, Mayumi Asahina, Takuji Suzuki, Shoichi Ito
Publikováno v:
Medical Education Online, Vol 29, Iss 1 (2024)
ABSTRACTIn clinical clerkship (CC), medical students can practice evidence-based medicine (EBM) with their assigned patients. Although CC can be a valuable opportunity for EBM education, the impact of EBM training, including long-term behavioral chan
Externí odkaz:
https://doaj.org/article/a96cfc9fb23643b29aa44cc81dec2924
Autor:
Ayaka Kuriyama, Hajime Kasai, Kiyoshi Shikino, Yuki Shiko, Chiaki Kawame, Kenichiro Takeda, Hiroshi Tajima, Nami Hayama, Takuji Suzuki, Shoichi Ito
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0282337 (2023)
IntroductionThe study aimed to evaluate visualization-based training's effects on lung auscultation during clinical clerkship (CC) in the Department of Respiratory Medicine on student skills and confidence.MethodsThe study period was December 2020-No
Externí odkaz:
https://doaj.org/article/5ea8014cd88e44dc88fcea8fb6014431
Autor:
Tetsuo Fujita, Nami Hayama, Tsuguko Kuroki, Yuka Shiraishi, Hiroyuki Amano, Makoto Nakamura, Satoshi Hirano, Nao Aramaki, Shuji Ichinose, Shinichiro Shimizu, Hiroshi Tabeta, Sukeyuki Nakamura
Publikováno v:
Thoracic Cancer, Vol 10, Iss 11, Pp 2179-2182 (2019)
The safety of treatment with immune‐checkpoint inhibitors prior to thoracic surgery in patients with non‐small cell lung cancer (NSCLC) remains unclear. Here, we describe the case of a 62‐year‐old woman with NSCLC with programmed death ligand
Externí odkaz:
https://doaj.org/article/f9e3b252545f479a9f0a72c5574f0bcb
Autor:
Hiroshi Tabeta, Nami Hayama, Satoshi Hirano, Tsuguko Kuroki, Sukeyuki Nakamura, Hiroyuki Amano, Makoto Nakamura, Takashi Aruga, Yuka Shiraishi, Tetsuo Fujita
Publikováno v:
Haigan. 60:187-191
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb234c70419d073e0eec50ca1df3b644
https://doi.org/10.2482/haigan.60.187
https://doi.org/10.2482/haigan.60.187
Autor:
Tsuguko Kuroki, Hiroyuki Amano, Satoshi Hirano, Yuka Shiraishi, Sukeyuki Nakamura, Hiroshi Tabeta, Nami Hayama, Makoto Nakamura, Tetsuo Fujita, Shinichiro Shimizu
Publikováno v:
Journal of Thoracic Oncology. 15:e20-e22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ee103d9e15ea1a9c4a1baece83db3ff
https://doi.org/10.1016/j.jtho.2019.10.012
https://doi.org/10.1016/j.jtho.2019.10.012
Autor:
Nao Aramaki, Shuji Ichinose, Nami Hayama, Shinichiro Shimizu, Satoshi Hirano, Makoto Nakamura, Tetsuo Fujita, Hiroshi Tabeta, Hiroyuki Amano, Tsuguko Kuroki, Sukeyuki Nakamura, Yuka Shiraishi
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 10, Iss 11, Pp 2179-2182 (2019)
Thoracic Cancer, Vol 10, Iss 11, Pp 2179-2182 (2019)
The safety of treatment with immune‐checkpoint inhibitors prior to thoracic surgery in patients with non‐small cell lung cancer (NSCLC) remains unclear. Here, we describe the case of a 62‐year‐old woman with NSCLC with programmed death ligand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::546ae756d0f404b2a21ae444f947669f
https://doi.org/10.1111/1759-7714.13194
https://doi.org/10.1111/1759-7714.13194
Autor:
Nami Hayama, Satoshi Hirano, Sukeyuki Nakamura, Hiroshi Tabeta, Tsuguko Kuroki, Yuka Shiraishi, Makoto Nakamura, Tetsuo Fujita, Hiroyuki Amano
Publikováno v:
Internal Medicine
Objective Pembrolizumab has benefited patients with advanced non-small-cell lung cancer (NSCLC) with a programmed death-ligand (PD-L) 1 high expression, but little information is available regarding its safety for patients with interstitial lung dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2363f10627cc72058a5267e6b06fbe7a
https://pubmed.ncbi.nlm.nih.gov/32389949
https://pubmed.ncbi.nlm.nih.gov/32389949
Autor:
Nami Hayama, Hideki T. Miyazaki, Shinichiro Shimizu, Satoshi Hirano, Toru Igari, Hideaki Yano, Yoshimasa Gohda
Publikováno v:
Chinese Clinical Oncology. 10:29-29
Pseudomyxoma peritonei is a rare disease with a reported prevalence of about 1-3 per million people annually. Cytoreductive surgery and perioperative hyperthermic intraperitoneal chemotherapy are considered as treatment options improving disease cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e909a88973812e3d4fb12e0a2b22a17
https://doi.org/10.21037/cco-21-2
https://doi.org/10.21037/cco-21-2
Autor:
Hiroyuki Amano, Sukeyuki Nakamura, Makoto Nakamura, Satoshi Hirano, Tsuguko Kuroki, Tetsuo Fujita, Yuka Shiraishi, Nami Hayama, Hiroshi Tabeta
Publikováno v:
In vivo (Athens, Greece). 33(6)
Background/Aim: Pemetrexed plus platinum followed by pemetrexed maintenance has been one of the standard first-line treatments in advanced nonsquamous non-small cell lung cancer (NSCLC), but little is known regarding its safety and efficacy for patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::821074c0a5db0f80f79a3f4faddab29c
https://pubmed.ncbi.nlm.nih.gov/31662538
https://pubmed.ncbi.nlm.nih.gov/31662538
Autor:
Hiroyuki Amano, Makoto Nakamura, Nami Hayama, Hiroshi Tabeta, Tetsuo Fujita, Yuri Suzuki, Satoshi Hirano, Sukeyuki Nakamura
Publikováno v:
Cancer Reports and Reviews. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b6c9667d144c719247d78397e648076
https://doi.org/10.15761/crr.1000166
https://doi.org/10.15761/crr.1000166